Results for tag: "Eldecalcitol"

Eldecalcitol is a drug used to treat musculoskeletal disorders, such as osteoporosis and Paget's disease. It is a vitamin D analogue, and works by increasing the absorption of calcium in the body, which helps to strengthen bones. It is available in both oral and injectable forms, and is typically prescribed for long-term use. Eldecalcitol is a relatively new drug, and is not yet widely available. It is currently approved for use in Japan, and is in the process of being approved in other countries. Clinical trials have shown that it is effective in treating musculoskeletal disorders, and is generally well-tolerated. The Eldecalcitol market is still in its early stages, but is expected to grow in the coming years. As more countries approve the drug, and as awareness of its benefits increases, the market is likely to expand. Some companies in the Eldecalcitol market include Eisai Co., Ltd., Daiichi Sankyo Co., Ltd., and Takeda Pharmaceutical Co., Ltd. Show Less Read more